Is TTNP or JNJ a better dividend investment in 2026?

TTNP currently yields 85.47% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: TTNP offers higher current income.

What is the dividend yield difference between TTNP and JNJ?

TTNP has a forward dividend yield of 85.47% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 82.11 percentage points.

Home › Compare › TTNP vs JNJ

TTNP vs JNJ: Dividend Comparison 2026

TTNP yields 85.47% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TTNP wins by $2.09M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TTNP

● Live price

85.47%

Share price

$2.34

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.11M

Annual income

$639,398.81

Full TTNP calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — TTNP vs JNJ

📍 TTNP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TTNP	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TTNP + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TTNP pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TTNP

Annual income on $10K today (after 15% tax)

$7,264.96/yr

After 10yr DRIP, annual income (after tax)

$543,488.99/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, TTNP beats the other by $542,785.38/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TTNP + JNJ for your $10,000?

TTNP: 50%JNJ: 50%

100% JNJ50/50100% TTNP

Portfolio after 10yr

$1.07M

Annual income

$320,113.29/yr

Blended yield

30.04%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TTNP

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-240.6

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TTNP buys

JNJ buys

No recent congressional trades found for TTNP or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTTNPJNJ

Forward yield	85.47% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$2.11M	$20.0K ✓
Annual income after 10y	$639,398.81 ✓	$827.78
Total dividends collected	$1.85M	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: TTNP vs JNJ ($10,000, DRIP)

Year	TTNP Portfolio	TTNP Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$19,247	$8,547.01	$10,676	$355.77	+$8.6K → TTNP
2	$35,969	$15,374.24	$11,407	$389.39	+$24.6K → TTNP
3	$65,338	$26,851.55	$12,198	$426.53	+$53.1K → TTNP
4	$115,497	$45,585.62	$13,056	$467.62	+$102.4K → TTNP
5	$198,892	$75,309.60	$13,987	$513.12	+$184.9K → TTNP
6	$334,016	$121,202.50	$14,998	$563.56	+$319.0K → TTNP
7	$547,628	$190,230.15	$16,098	$619.52	+$531.5K → TTNP
8	$877,445	$291,482.95	$17,295	$681.69	+$860.1K → TTNP
9	$1,375,345	$436,479.30	$18,599	$750.82	+$1.36M → TTNP
10	$2,111,018	$639,398.81	$20,022	$827.78	+$2.09M → TTNP

TTNP vs JNJ: Complete Analysis 2026

TTNP — Stock

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

Full TTNP Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this TTNP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TTNP vs SCHD TTNP vs JEPI TTNP vs O TTNP vs KO TTNP vs MAIN TTNP vs ABBV TTNP vs MRK TTNP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.